Randomised controlled trial of genetic amniocentesis in 4606 low-risk women
- PMID: 2423826
- DOI: 10.1016/s0140-6736(86)91218-3
Randomised controlled trial of genetic amniocentesis in 4606 low-risk women
Abstract
Outcome of pregnancy after amniocentesis was studied in a randomised controlled trial of 4606 women, age-range 25-34 years, without known risk of genetic disease. Spontaneous abortion rate was 1.7% in the study group after amniocentesis and 0.7% in the control group after ultrasound (relative risk 2.3). In the study group, increased levels of maternal serum alpha-fetoprotein before amniocentesis, perforation of the placenta during amniocentesis, and withdrawal of discoloured amniotic fluid were associated with an increased risk of spontaneous abortion. In the first six weeks after amniocentesis/ultrasound scan, amniotic fluid leakage occurred more often in the study group but there was no difference in the rate of vaginal bleeding. Frequency of postural malformations in the infants in the two groups was the same. In the study group, respiratory distress syndrome was diagnosed more often (relative risk 2.1) and more babies were treated for pneumonia (relative risk 2.5).
Similar articles
-
Feto-maternal haemorrhage associated with genetic amniocentesis: results of a randomized trial.Br J Obstet Gynaecol. 1987 Jun;94(6):528-34. doi: 10.1111/j.1471-0528.1987.tb03145.x. Br J Obstet Gynaecol. 1987. PMID: 2441735 Clinical Trial.
-
Amniocentesis in early pregnancy using free-hand needle technique under ultrasonic control.Int J Gynaecol Obstet. 1981 Apr;19(2):149-54. doi: 10.1016/0020-7292(81)90055-2. Int J Gynaecol Obstet. 1981. PMID: 6119247
-
Fetal-maternal bleeding associated with genetic amniocentesis.Obstet Gynecol. 1980 Jan;55(1):48-54. Obstet Gynecol. 1980. PMID: 6153239
-
[Prenatal diagnosis of fetal malformations from the obstetrician's viewpoint].Wien Klin Wochenschr. 1983 Feb 4;95(3):67-78. Wien Klin Wochenschr. 1983. PMID: 6190319 Review. German.
-
[Complications from chorionic villus sampling and amniocentesis].J Gynecol Obstet Biol Reprod (Paris). 1994;23(5):476-80. J Gynecol Obstet Biol Reprod (Paris). 1994. PMID: 7983305 Review. French. No abstract available.
Cited by
-
Integration of targeted sequencing and pseudo-tetraploid genotyping into clinically assisted decision support for β-thalassemia invasive prenatal diagnosis.PLoS One. 2023 Apr 4;18(4):e0283668. doi: 10.1371/journal.pone.0283668. eCollection 2023. PLoS One. 2023. PMID: 37014894 Free PMC article.
-
Combined Model-Based Prediction for Non-Invasive Prenatal Screening.Int J Mol Sci. 2022 Nov 30;23(23):14990. doi: 10.3390/ijms232314990. Int J Mol Sci. 2022. PMID: 36499318 Free PMC article.
-
Does a High-Risk (>1/50) Result for First-Trimester Combined Screening Always Entail Invasive Testing? Which Patients from This Group Might Benefit from cfDNA Testing?Biomedicines. 2022 Oct 14;10(10):2579. doi: 10.3390/biomedicines10102579. Biomedicines. 2022. PMID: 36289845 Free PMC article.
-
Noninvasive fetal genotyping of single nucleotide variants and linkage analysis for prenatal diagnosis of monogenic disorders.Hum Genomics. 2022 Jul 27;16(1):28. doi: 10.1186/s40246-022-00400-4. Hum Genomics. 2022. PMID: 35897115 Free PMC article.
-
The role of intraamniotic inflammation in threatened midtrimester miscarriage.Am J Obstet Gynecol. 2022 Dec;227(6):895.e1-895.e13. doi: 10.1016/j.ajog.2022.07.007. Epub 2022 Jul 16. Am J Obstet Gynecol. 2022. PMID: 35843271 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
